30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
Australia Pharmaceuticals

Clinuvel Pharmaceuticals Ltd (CUV)

Track

The most recent insider trading activity at Clinuvel Pharmaceuticals Ltd occurred on September 19, 2023, with a BUY transaction by Philippe Wolgen valued at $29,813.86. Prior to this, Philippe Wolgen also made a BUY transaction on June 26, 2023. Earlier transactions include BUYs by Jeffrey Rosenfeld in November 2022 and February 2022.
Top insiders
Trades
Philippe Wolgen
1 purchase — total 29,814 AUD
Buy 19 Sep 2023
Value A$513,209.43 | Price 183.04 | Shares 51,634
Buy 26 Jun 2023
Value A$1,485,586.52 | Price 252.80 | Shares 59,433
Buy 4 Nov 2022
Value A$5,832.00 | Price 19.44 | Shares 300
Buy 25 Feb 2022
Value A$9,263.50 | Price 19.10 | Shares 485
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-09-20 2023-09-19 B Purchase Philippe Wolgen Director
51,634
183.04
A$513,209 		51,634 183.04 A$513,209
2023-06-28 2023-06-26 B Purchase Philippe Wolgen Director
59,433
252.80
A$1,485,587 		59,433 252.80 A$1,485,587
2022-11-07 2022-11-04 B Purchase Jeffrey Rosenfeld Director
77,810
331.31
A$4,639,710 		77,810 331.31 A$4,639,710
2022-03-02 2022-02-25 B Purchase Jeffrey Rosenfeld Director
485
19.10
A$9,264 		485 19.10 A$9,264
Explore more

More insider trading research around Clinuvel Pharmaceuticals Ltd

More insider trades in Australia
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in Asia-Pacific